Byrne Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-469	Closed	-$29.9K	–	589
2025 Q1	$29.9K	Buy	+469	New	+$29.9K	0.02%	298
2023 Q3	–	Sell	-40	Closed	-$5K	–	583
2023 Q2	$5K	Buy	+40	New	+$5K	﹤0.01%	467